Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIMK1 | P53667 | 6/20 | 0.36 |
| ▸ | LIMK2 | P53671 | 1/20 | 0.36 |
| ▸ | ABCG2 | Q9UNQ0 | 6/20 | 0.36 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.36 |
| ▸ | AHR | P35869 | 2/20 | 0.36 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | FYN | P06241 | 1/20 | 0.36 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.36 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.33 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19081800 | 0.95 | CYP1A1 (0.37) | ABCG2CYP1A1AHRPAX8CYP1A2 | |
| SCHEMBL19081875 | 0.94 | ABCG2 (0.39) | LIMK1LIMK2ABCG2CYP1A1AHR | |
| SCHEMBL19082024 | 0.94 | ABCG2 (0.39) | LIMK1LIMK2ABCG2CYP1A1AHR | |
| SCHEMBL19081979 | 0.92 | ABCG2 (0.35) | LIMK1LIMK2ABCG2CYP1A1AHR | |
| SCHEMBL18842988 | 0.91 | PLA2G2A (0.34) | LIMK1LIMK2ABCG2CYP1A1AHR | |
| SCHEMBL19081894 | 0.90 | ABCG2 (0.40) | LIMK1LIMK2ABCG2CYP1A1AHR | |
| SCHEMBL19081823 | 0.90 | ABCG2 (0.40) | LIMK1ABCG2CYP1A1AHRPAX8 | |
| SCHEMBL19081845 | 0.89 | CYP1A1 (0.40) | LIMK1LIMK2ABCG2CYP1A1CYP1A2 | |
| SCHEMBL19081785 | 0.88 | ALOX5 (0.36) | LIMK1ABCG2CYP1A1AHRPAX8 | |
| SCHEMBL19076734 | 0.87 | ALOX5 (0.39) | ABCG2CYP1A1AHRPAX8CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10553800-B2 | Condensed cyclic compound and an organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-02-04 | — | — | US | disclosed |
| US-20170194572-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-07-06 | — | — | US | disclosed |
| US-20170194572-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10553800-B2 | Condensed cyclic compound and an organic light-emitting device including the same | CRY1, CRY2, CCNT1 | LIMK1 440/4885LIMK2 1292/4885ABCG2 4823/4885 |
| US-20170194572-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNT1 | LIMK1 440/4885LIMK2 1292/4885ABCG2 4823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.